“…The results of the included reviews document the prevalence, clinical outcomes, prognosis, factors affecting morbidity and mortality, along with suggestions for future oncology care during and after the pandemic. The included reviews were conducted in USA [13,18], China [14,15 && ], Korea [16], Australia [17], UK [19] and Italy [20]. The first authors of all the reviews were a part of the medical discipline [13,14,15 [16].…”